Structural basis for transport and inhibition of nucleotide sugar transport in pathogenic fungi

GDP-Mannose transporters are Golgi-localised solute carriers that are essential for the virulence of pathogenic fungi, serving as critical components of fungal glycosylation pathways. However, the mechanism by which nucleotide sugars are recognised and transported across the Golgi membrane remains unclear, hindering efforts to develop effective inhibitors that could serve as distinct antifungal agents. Here, we present cryo-EM structures of the GDP-Mannose transporter, Vrg4, from Candida albicans in complex with nanobodies in both the cytoplasmic and Golgi-facing states. Structural comparisons between these two states, in addition to a GDP-mannose bound structure, demonstrate the importance of ligand movement during transport. Additionally, we demonstrate the ability of the nanobodies to specifically inhibit Vrg4, presenting proof-of-principle that nanobodies can be used as effective inhibitors of nucleotide sugar transport and glycosylation in cells.

Authors

Institutions

Publication Details

Journal
Nature Communications
Published
2026-05-02
DOI
https://doi.org/10.1038/s41467-026-72729-6
Primary Topic
Antifungal resistance and susceptibility
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Structural basis for transport and inhibition of nucleotide sugar transport in pathogenic fungi

Joanne L. Parker, Susan M. Lea, Justin C. Deme, B Feddersen et al.
Nature Communications
Antifungal resistance and susceptibility
article

Structural basis for transport and inhibition of nucleotide sugar transport in pathogenic fungi

Joanne L. Parker, Susan M. Lea, Justin C. Deme, B Feddersen, Simon Newstead
article en

Abstract

GDP-Mannose transporters are Golgi-localised solute carriers that are essential for the virulence of pathogenic fungi, serving as critical components of fungal glycosylation pathways. However, the mechanism by which nucleotide sugars are recognised and transported across the Golgi membrane remains unclear, hindering efforts to develop effective inhibitors that could serve as distinct antifungal agents. Here, we present cryo-EM structures of the GDP-Mannose transporter, Vrg4, from Candida albicans in complex with nanobodies in both the cytoplasmic and Golgi-facing states. Structural comparisons between these two states, in addition to a GDP-mannose bound structure, demonstrate the importance of ligand movement during transport. Additionally, we demonstrate the ability of the nanobodies to specifically inhibit Vrg4, presenting proof-of-principle that nanobodies can be used as effective inhibitors of nucleotide sugar transport and glycosylation in cells.

Nature Communications
St. Jude Children's Research Hospital (US), University of Oxford (GB), Frederick National Laboratory for Cancer Research (US), National Cancer Institute (US), Science Oxford (GB), Center for Cancer Research (US)
Wellcome, Medical Research Council
Decent work and economic growth
Openalex Percentile: Top 11%
Antifungal resistance and susceptibility
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Structural basis for transport and inhibition of nucleotide sugar transport in pathogenic fungi — Joanne L. Parker, Susan M. Lea, et al. · Nature Communications (2026) | TGRS Research Map | TGRS